NEW YORK In a nutshell, this program gives any legislative body — state or local — debating around whether a prescription ought to be required in the purchase of a pseudoephedrine product one less reason to pull the trigger on that decision. And it’s a pretty big reason. Before, the argument could be made that implementing a program like NPLEx was prohibitive because of the associated cost.
That’s a sound argument even if it means making PSE prescription-only for all the wrong reasons. And that’s true especially in today’s economy, where state and local governments both are doing their level best to continue providing community-wide services despite dwindling coffers.
But now the money argument shifts in the other direction, because now there are no costs associated with programs like NPLEx for state or local governments, except maybe in prosecuting and housing criminals. And that’s a cost that should pay dividends going forward, because they’ll actually be purging a lot of these methamphetamine-addicted criminals from mainstream society.
The fact is, that’s potentially the best benefit from this program, pulling those criminals off the streets. Requiring a prescription for PSE is only a hurdle for an addict. It’s not going to stop them altogether; though it will stop a legitimate consumer from realizing accessible symptom relief from a cold.